- Home
- ZTS vs VST Comparison
ZTS vs VST Comparison
Compare ZTS & VST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZTS
- VST
- Stock Information
- Founded
- ZTS 1952
- VST 1882
- Country
- ZTS United States
- VST United States
- Employees
- ZTS N/A
- VST N/A
- Industry
- ZTS Biotechnology: Pharmaceutical Preparations
- VST Electric Utilities: Central
- Sector
- ZTS Health Care
- VST Utilities
- Exchange
- ZTS Nasdaq
- VST Nasdaq
- Market Cap
- ZTS 66.2B
- VST 71.0B
- IPO Year
- ZTS 2013
- VST N/A
- Fundamental
- Price
- ZTS $127.66
- VST $177.65
- Analyst Decision
- ZTS Buy
- VST Buy
- Analyst Count
- ZTS 10
- VST 11
- Target Price
- ZTS $178.89
- VST $234.09
- AVG Volume (30 Days)
- ZTS 5.4M
- VST 4.3M
- Earning Date
- ZTS 11-04-2025
- VST 11-06-2025
- Dividend Yield
- ZTS 1.57%
- VST 0.51%
- EPS Growth
- ZTS 11.64
- VST N/A
- EPS
- ZTS 5.94
- VST 2.77
- Revenue
- ZTS $9,397,000,000.00
- VST $17,191,000,000.00
- Revenue This Year
- ZTS $3.84
- VST $17.21
- Revenue Next Year
- ZTS $5.89
- VST $12.33
- P/E Ratio
- ZTS $21.51
- VST $63.72
- Revenue Growth
- ZTS 2.68
- VST 5.69
- 52 Week Low
- ZTS $115.25
- VST $90.51
- 52 Week High
- ZTS $181.85
- VST $219.82
- Technical
- Relative Strength Index (RSI)
- ZTS 48.93
- VST 45.57
- Support Level
- ZTS $115.25
- VST $162.44
- Resistance Level
- ZTS $122.96
- VST $175.20
- Average True Range (ATR)
- ZTS 3.01
- VST 9.48
- MACD
- ZTS 1.43
- VST 0.07
- Stochastic Oscillator
- ZTS 90.59
- VST 43.22
About ZTS Zoetis Inc.
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on), and nearly 65% from companion animal (dogs, horses, cats) products. Its us business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
About VST Vistra Corp.
Vistra Corp. is one of the largest power producers and retail energy providers in the US. Following the 2024 Energy Harbor acquisition, Vistra owns 41 gigawatts of nuclear, coal, natural gas, solar, and energy storage assets. The Lotus Partners asset purchase would add 2.6 GW of natural gas generation. Its retail electricity business serves 5 million customers in 20 states, including almost a third of all Texas electricity consumers. Vistra emerged from the Energy Future Holdings bankruptcy as a stand-alone entity in 2016. It acquired Dynegy in 2018.